Skip to content

A clinical study to compare the effects of two drugs, Magnesium sulphate and Dexmedetomidine for decreasing blood pressure and pulse rate in patients undergoing micro-surgery for gall bladder removal.

A comparative study between intravenous Magnesium sulphate and Dexmedetomidine for attenuation of cardiovascular stress response during pneumoperitoneum in patients undergoing laparoscopic cholecystectomy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013292
Enrollment
70
Registered
2018-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- GALL STONE DISEASE CHOLELITHIASIS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY

Interventions

Intervention1: MAGNESIUM SULPHATE : Patients in Magnesium sulphate group received a IV bolus 40mg/kg in normal saline, followed by an IV infusion of 15mg/kg/hr. Bolus volume of the study drug was adj

Sponsors

Burdwan Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA Physical Status I and II 2. Age-18 to 50 years 3. Sex â?? Both Male and Female 4. Patients undergoing elective laparoscopic cholecystectomy

Exclusion criteria

Exclusion criteria: Following patients were excluded from this study:- 1. Patient refusal 2. ASA physical status III and IV, 3. Patients having difficult airway, 4. Bronchial asthma, Chronic Obstructive Pulmonary Disease or any other respiratory diseases, 5. Liver diseases, 6. Heart diseases, Conduction blocks 7. Hypertensive patients 8. Patients taking clonidine, methyl-dopa, beta blockers, benzodiazepines, MAO inhibitors 9. Morbid obesity, 10. Renal diseases, 11. Diabetes, 12. Neurological illnesses, Myopathies, and 13. Allergy to the study drugs

Design outcomes

Primary

MeasureTime frame
Heart Rate (HR) and Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) & Mean Arterial Pressure ( MAP), oxygen saturation (SpO2) were recorded before induction,during pneumoperitoneum and after extubationTimepoint: During surgery Baseline ,At the end of loading dose 1 minute after endotracheal intubation,Before pneumoperitoneum and 1 minute, 5 minutes ,10 minutes ,15 minutes ,30 minutes ,45 minutes ,60 minutes ,75 minutes after pneumoperitoneum and 5 minutes after release of pneumoperitoneum and After extubation 5 minutes.

Secondary

MeasureTime frame
bradycardia, tachycardia (HR more than 20% of pre-operative level respectively on two consecutive readings or 100/ min.), clinically significant hypotension and hypertension (MAP less than or more than 20% of pre-operative level respectively on two consecutive readings and sedation score more than Ramsay Sedation Score 4, respiratory depression (SpO2 less than 90%) etc. as adverse effects. Sedation level was measured at 5 minutes after extubationTimepoint: During surgery Baseline ,At the end of loading dose 1 minute after endotracheal intubation,Before pneumoperitoneum and 1 minute, 5 minutes ,10 minutes ,15 minutes ,30 minutes ,45 minutes ,60 minutes ,75 minutes after pneumoperitoneum and 5 minutes after release of pneumoperitoneum and After extubation 5 minutes.

Countries

India

Contacts

Public ContactDebayan Bhattacharya

Department of Anesthesiology Burdwan Medical College & Hospital

tirthasishm@rediffmail.com9475862895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026